InsidersTradesSigma
Track the CanSino Biologics Inc. share price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Operating in the Health Care sector, CanSino Biologics Inc. has logged 3 insider filings. Market capitalisation: €5.8bn. The latest transaction was disclosed on 30 March 2026 (Purchase). Among the most active insiders: Chao Shou Bai. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
CanSino Biologics Inc. es una empresa biofarmacéutica centrada en el desarrollo de vacunas y terapias innovadoras. Cotiza en la Bolsa de Hong Kong bajo el símbolo XHKG.